Intra-Cellular Therapies Prices $114 Million Public Offering of Common Stock

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/11/2026

1. SPCX
2. HUM
3. ALHC
4. T
5. PEP
6. TMUS
7. SPY
8. CVS
9. UNH
10. SBUX

Go back to Intra-Cellular Therapies Prices $114 Million Public Offering of Common Stock

Intra-Cellular Therapies (ITCI) PT Raised to $29 at Cowen

March 9, 2015 9:09 AM EDT

Cowen analyst Ritu Baral reiterated an Outperform rating and boosted the price target on Intra-Cellular Therapies (NASDAQ: ITCI) to $29.00 (from $24.00) following last'weeks conference.

Baral commented, "We are increasing our target from $24 to $29 based on positive from our survey and panel KOLs... More

Intra-Cellular Therapies (ITCI) Prices 4.75M Offering at $24/Share

March 6, 2015 6:14 AM EST

Intra-Cellular Therapies (Nasdaq: ITCI) announced the pricing of its previously announced underwritten public offering of 4,750,000 shares of its common stock at a public offering price of $24.00 per share. All of the shares in the offering will be sold by Intra-Cellular Therapies. Net proceeds to... More